Simona Chera

Position

Professor

Affiliation

Research groups

Research

The common denominator of my career is cell fate and identity maintenance in the context of cell decay and regeneration

During my PhD studies (UniGe, Switzerland) I studied the molecular mechanisms regulating cell fate during early regeneration (Chera et al., DevCell 2009). For my postdoc in Prof. Herrera laboratory (UniGe, Switzerland), I investigated the age-related cell conversion processes occurring in the post-natal mammalian pancreas, following the extreme loss of insulin expressing β-cells (Thorel et al., Nature,2010; Chera et al., Nature 2014; Furuyama et al., Nature, 2019). 

Upon my arrival at UoB, I directed my independent line of research at modulating the molecular circuits involved in cell-fate decisions and their involvement in diabetes. Briefly, by coupling classical and newly generated models of cell loss with genetic cell tracing, timed conditional gene expression and various omics assays we study the dynamic molecular fingerprint of pancreatic islet cells decay and regeneration, with focus on global regulators of cell identity maintenance processes (Mathisen et al.,ActaPhysiol 2023; Mathisen et al.,CommsBiol 2024; Mathisen et al.,MAD 2024). Besides the in vivo approach, we use patient-specific induced pluripotent stem cells (hiPSC) as disease models coupled with large-scale imaging and omics for studying islet cell fate acquisition and maintenance (Legøy et al., SciReports 2020; Legøy et al., Acta Physiol, 2020; Unger et al., Int. J. Dev. Biol.2024). 

Moreover, my collaborative works with Dibner’s (UniGE - Switzerland, Gen&Dev 2020; Plos Biology 2022; Cell Rep Med 2023; iScience 2024), Herrera’s (UniGe, Nat.Cell.Biol 2018), Scholz’s (UoO - Norway Front. Bioeng. Biotechnol. 2024, Transplant International 2024), Vacaru's (ICBPNS - Romania, Sci.Rep 2024) and Kim’s (Sandford - US, SciReports 2022) labs strongly contributed to understanding stress responses in the islet. My research on islet cell biology has been funded via NFR FRIPRO (2016-2021, 2021-2026, 2026-2030), NovoNordiskFundation (2015-2020, 2021-2026), EØS (2020-2024), Diabetes-forbundet (2021-2022), NCMM (2019-2021) and Trond Mohn Stiftelse (2022-2027). 

Recently, we developed a second line of research directed at understanding cell identity changes in cancers, which is generously financed by Kristian Gerhard Jebsen Foundation (2024-2029).   

Teaching

Methods in Medical Cell Biology - BMED320 ECTS credits: 25

Future medicine - ELMED303 ECTS credits: 3

Publications
Poster
Lecture
Academic lecture
Academic article
Editorial
Abstract
Popular scientific article
Academic literature review

See a complete overview of publications in Cristin.